William N. O'Connor
Medical Practice in Lexington, KY

License number
Kentucky 18301
Issued Date
Mar 25, 1976
Expiration Date
Feb 28, 2018
Category
Pathology
Type
Hospital Based
Address
Address
800 Pathology, Ukmc, Ms129, 800 Rose St, Lexington, KY 40536
Education
University College Cork, National University of Ireland, 1972
Phone
(859) 257-5357 (Work)

Professional information

William Noel O'Connor Photo 1

William Noel O'Connor, Lexington KY

Specialties:
Pathologist
Address:
800 Rose St, Lexington, KY 40536
Education:
National University of Ireland - Doctor of Medicine*
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)*


William O'Connor Photo 2

William O'Connor, Lexington KY

Work:
800 Rose St
800 Rose St, Lexington, KY 40536


William O'Connor Photo 3

Methods And Apparatus For In Vivo Identification And Characterization Of Vulnerable Atherosclerotic Plaques

US Patent:
2001004, Nov 29, 2001
Filed:
Jan 24, 2001
Appl. No.:
09/768920
Inventors:
Pedro Moreno - Lexington KY, US
Robert Lodder - Nicholasville KY, US
William O'Connor - Lexington KY, US
James Muller - Lexington KY, US
Assignee:
University of Kentucky Research Foundation, Kentucky Corporation
International Classification:
A61B006/00
US Classification:
600/475000, 600/476000, 600/477000, 250/338100, 250/339010, 250/339060, 250/339110
Abstract:
Methods and apparatus for analyzing the chemical composition of vulnerable plaques with an intravascular catheter having a near-infrared light source, a fiber-optic probe, a mechanism for directing the light from the light source into a blood vessel, and detectors for detecting light reflected or scattered by the tissue. The light source may be a tunable laser, and may transmit an incident beam having a wavelength ranging from 1400 to 4100 nm. A computer may be included to receive and process the spectral data in the analysis of the vulnerable plaques. A catheter system may be configured to provide near-IR spectrometric imaging of arteries to non-destructively locate and determine lipid pool and fibrous cap size and composition. Additionally, mediators and cellular components may be also determined that are typically associated with vulnerable plaques which have an increased risk of rupture. The lipid pool, fibrous cap, and inflammatory response may serve as an in vivo marker for vulnerable atherosclerotic plaques. Methods are further provided for prospectively identifying and characterizing vulnerable plaques which may include the steps of focusing near-IR light onto a blood vessel wall; detecting the scattered light in the region; and analyzing the resulting spectra across the full preselected wavelength range, particularly in the ranges that include identifying peaks for vulnerable plaque constituents.